BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31595628)

  • 21. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
    Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
    Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic analysis demonstrates that histologically-defined astroblastomas are molecularly heterogeneous and that tumors with MN1 rearrangement exhibit the most favorable prognosis.
    Lehman NL; Usubalieva A; Lin T; Allen SJ; Tran QT; Mobley BC; McLendon RE; Schniederjan MJ; Georgescu MM; Couce M; Dulai MS; Raisanen JM; Al Abbadi M; Palmer CA; Hattab EM; Orr BA
    Acta Neuropathol Commun; 2019 Mar; 7(1):42. PubMed ID: 30876455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical ependymoma or monomorphous angiocentric glioma?
    Lum DJ; Halliday W; Watson M; Smith A; Law A
    Neuropathology; 2008 Feb; 28(1):81-6. PubMed ID: 18021197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel LARGE1-AFF2 fusion expanding the molecular alterations associated with the methylation class of neuroepithelial tumors with PATZ1 fusions.
    Tauziède-Espariat A; Chotard G; le Loarer F; Baud J; Azmani R; Dangouloff-Ros V; Boddaert N; Icher-de-Bouyn C; Gimbert E; Hasty L; Métais A; Chrétien F; Varlet P;
    Acta Neuropathol Commun; 2022 Feb; 10(1):15. PubMed ID: 35115049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GOPC-ROS1 Fusion Due to Microdeletion at 6q22 Is an Oncogenic Driver in a Subset of Pediatric Gliomas and Glioneuronal Tumors.
    Richardson TE; Tang K; Vasudevaraja V; Serrano J; William CM; Mirchia K; Pierson CR; Leonard JR; AbdelBaki MS; Schieffer KM; Cottrell CE; Tovar-Spinoza Z; Comito MA; Boué DR; Jour G; Snuderl M
    J Neuropathol Exp Neurol; 2019 Dec; 78(12):1089-1099. PubMed ID: 31626289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EWSR1-PATZ1 gene fusion may define a new glioneuronal tumor entity.
    Siegfried A; Rousseau A; Maurage CA; Pericart S; Nicaise Y; Escudie F; Grand D; Delrieu A; Gomez-Brouchet A; Le Guellec S; Franchet C; Boetto S; Vinchon M; Sol JC; Roux FE; Rigau V; Bertozzi AI; Jones DTW; Figarella-Branger D; Uro-Coste E
    Brain Pathol; 2019 Jan; 29(1):53-62. PubMed ID: 29679497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncogenic Fusions in Gliomas: An Institutional Experience.
    Polivka J; Svajdler M; Priban V; Mracek J; Kasik P; Martinek P; Ptakova N; Sharif Bagheri M; Shetti D; Pesta M; Potuznik P; Topolcan O
    Anticancer Res; 2022 Apr; 42(4):1933-1939. PubMed ID: 35347013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas.
    Tian Y; Rich BE; Vena N; Craig JM; Macconaill LE; Rajaram V; Goldman S; Taha H; Mahmoud M; Ozek M; Sav A; Longtine JA; Lindeman NI; Garraway LA; Ligon AH; Stiles CD; Santagata S; Chan JA; Kieran MW; Ligon KL
    J Mol Diagn; 2011 Nov; 13(6):669-77. PubMed ID: 21884820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT).
    Gessi M; Lambert SR; Lauriola L; Waha A; Collins VP; Pietsch T
    J Neurooncol; 2012 Oct; 110(1):21-5. PubMed ID: 22814862
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Well-differentiated pediatric glial neoplasms with features of oligodendroglioma, angiocentric glioma and dysembryoplastic neuroepithelial tumors: a morphological diagnostic challenge.
    Keser H; Barnes M; Moes G; Lee HS; Tıhan T
    Turk Patoloji Derg; 2014; 30(1):23-9. PubMed ID: 24448703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors.
    Ellison DW; Aldape KD; Capper D; Fouladi M; Gilbert MR; Gilbertson RJ; Hawkins C; Merchant TE; Pajtler K; Venneti S; Louis DN
    Brain Pathol; 2020 Sep; 30(5):863-866. PubMed ID: 32502305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.
    Kline CN; Joseph NM; Grenert JP; van Ziffle J; Talevich E; Onodera C; Aboian M; Cha S; Raleigh DR; Braunstein S; Torkildson J; Samuel D; Bloomer M; Campomanes AGA; Banerjee A; Butowski N; Raffel C; Tihan T; Bollen AW; Phillips JJ; Korn WM; Yeh I; Bastian BC; Gupta N; Mueller S; Perry A; Nicolaides T; Solomon DA
    Neuro Oncol; 2017 May; 19(5):699-709. PubMed ID: 28453743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Profiling Reclassifies Adult Astroblastoma into Known and Clinically Distinct Tumor Entities with Frequent Mitogen-Activated Protein Kinase Pathway Alterations.
    Boisseau W; Euskirchen P; Mokhtari K; Dehais C; Touat M; Hoang-Xuan K; Sanson M; Capelle L; Nouet A; Karachi C; Bielle F; Guégan J; Marie Y; Martin-Duverneuil N; Taillandier L; Rousseau A; Delattre JY; Idbaih A
    Oncologist; 2019 Dec; 24(12):1584-1592. PubMed ID: 31346129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The differential diagnosis of pilocytic astrocytoma with atypical features and malignant glioma: an analysis of 16 cases with emphasis on distinguishing molecular features.
    Cykowski MD; Allen RA; Kanaly AC; Fung KM; Marshall R; Perry A; Stolzenberg ED; Dunn ST
    J Neurooncol; 2013 Dec; 115(3):477-86. PubMed ID: 24057326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosome band 7q34 deletions resulting in KIAA1549-BRAF and FAM131B-BRAF fusions in pediatric low-grade Gliomas.
    Roth JJ; Santi M; Pollock AN; Harding BN; Rorke-Adams LB; Tooke LS; Biegel JA
    Brain Pathol; 2015 Mar; 25(2):182-92. PubMed ID: 25040262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis.
    Antonelli M; Badiali M; Moi L; Buttarelli FR; Baldi C; Massimino M; Sanson M; Giangaspero F
    Pediatr Blood Cancer; 2015 Apr; 62(4):724-7. PubMed ID: 25382612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.